We are making inroads into the chronic pain market
Post# of 7796
(Total Views: 299)
Posted On: 09/12/2022 7:13:52 PM
We are making inroads into the chronic pain market, thankfully, and now it seems we are rapidly addressing the chronic wound market. Followers of the company have known this since forever and we wonder when everyone else will. C5, you know darn good and well I could not resist remarking on this tidbit. Thanks for the link. Whenever I see the, "Reimbursement Policies", my heart goes all pitter-patter, goosebumps, and my legs get wobbly.
"North America Likely to Emerge Dominant; Presence of Several Health Reimbursement Policies will Bode Well for Market Growth"
What will 2023 bring? CPT codes for "Reimbursement Policies", maybe?
I'm tellin' you folks right here and now. If we get CPT codes for insurance reimbursement there will be a serious SHTF scenario in terms of upward movement of the share price.
later, WBeacham
"North America Likely to Emerge Dominant; Presence of Several Health Reimbursement Policies will Bode Well for Market Growth"
What will 2023 bring? CPT codes for "Reimbursement Policies", maybe?
I'm tellin' you folks right here and now. If we get CPT codes for insurance reimbursement there will be a serious SHTF scenario in terms of upward movement of the share price.
later, WBeacham
(2)
(0)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼